Eversept Partners, LP Keros Therapeutics, Inc. Transaction History

Eversept Partners, LP

  • $1.33 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$42.4 - $70.11 $1.17 Million - $1.94 Million
-27,631 Closed
0 $0
Q1 2021

Nov 08, 2023
BUY
$54.0 - $75.28 $1.49 Million - $2.08 Million
27,631 New
27,631 $1.7 Million
Q1 2021

May 13, 2021
BUY
$54.0 - $75.28 $1.49 Million - $2.08 Million
27,631 New
27,631 $1.7 Million

Others Institutions Holding KROS

# of Institutions
153
Shares Held
26.7M
Call Options Held
47.6K
Put Options Held
34.5K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email